Anavo Therapeutics BV

📍 Leiden, Netherlands👥 25 employees💰 Last funded May 2023
Biotechnology Research🌐 anavotx.com
Website LinkedIn
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
Israel
1
Frequently asked questions
Who invested in Anavo Therapeutics BV?
Anavo Therapeutics BV has 2 investors on record on gritt.io.
When did Anavo Therapeutics BV last raise funding?
The most recent investment in Anavo Therapeutics BV recorded on gritt.io was in May 2023.
What industry is Anavo Therapeutics BV in?
Anavo Therapeutics BV operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Anavo Therapeutics BV based?
Anavo Therapeutics BV is headquartered in Leiden, Netherlands.